Delivery Order SPE2DB22D2218-SPE2DB24FR2PM
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,379.28 fixed-price delivery order is for the supply of RENVELA 0.8 GM POWDER PACKET 90S, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, is a firm fixed price delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical. The contract provides for the delivery of Renvela 0.8 GM powder packets over a performance period ending on April 2, 2024, with a ceiling value of $1,530.55. This delivery order falls under a larger indefinite delivery contract (IDC) awarded...
- This is a $1,603.92 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of RENVELA 800 MG TABLET 270S, a medication used to treat hyperphosphatemia. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,852.26 delivery order contract is for Renvela 800 mg tablets, a medication used to treat kidney disease. The contract has a firm fixed price and spans from the award date of January 22, 2024 through January 23, 2024. No set-aside designation was used for this award. AmerisourceBergen holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,172.47 firm fixed-price delivery order is for the provision of 800 mg Renvela tablets, a medication used to treat kidney disease. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, running through November...
- This federal contract award, valued at $2,580.07, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The award, a delivery order, is for the supply of Renvela 800 mg tablets. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a for-profit organization and a major provider of pharmaceutical products and medical supplies to U.S. government agencies, particularly the...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $3,837.83 fixed-price contract is for the delivery of Renvela 800 mg tablets, which are used to treat kidney disease. The contract has an ultimate completion date of September 12, 2024. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,269.20 Firm Fixed Price Delivery Order contract is for the supply of Velphoro 500 mg chewable tablets, a medication used to manage high phosphorus levels in patients with chronic kidney disease on dialysis. The contract has a completion date of June 4, 2024. AmerisourceBergen holds a significant $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,842.86 delivery order is for the supply of Velphoro 500 mg chewable tablets, a medication used to manage high phosphorus levels in patients with chronic kidney disease on dialysis. The contract has a firm fixed-price pricing type and an ultimate completion date of January 31, 2024. AmerisourceBergen holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,185.54 firm fixed-price delivery order is for the supply of Velphoro 500 mg chewable tablets, a medication used to treat high phosphorus levels in patients with chronic kidney disease on dialysis. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen...
- SPE2DB22D2218Indefinite Delivery Contract
- SPE2DB22D2218-SPE2DB24FR2PMDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,286.98 Firm Fixed Price Delivery Order is for the supply of RENVELA 2.4 GM POWDER PACKET 90S, a medication used for the treatment of chronic kidney disease. The contract has an ultimate completion date of May 15, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 5/14/24 |